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ABSTRACT 
The number of citations that a patent receives is considered an important indicator of the 
quality and impact of the patent. However, a variety of methods and data sources can be used to 
calculate this measure. This paper evaluates similarities between citation indicators that differ in 
terms of (a) the patent office where the focal patent application is filed; (b) whether citations 
from offices other than that of the application office are considered; and (c) whether the presence 
of patent families is taken into account. We analyze the correlations between these different 
indicators and the overlap between patents identified as highly cited by the various measures. 
Our findings reveal that the citation indicators obtained differ substantially. Favoring one way of 
calculating a citation indicator over another has non-trivial consequences and, hence, should be 
given explicit consideration. Correcting for patent families, especially when using a broader 
definition (INPADOC), provides the most uniform results. 
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INTRODUCTION 
The number of times that patents are cited by other patents2 can be used to complement 
the mere counting of patented inventions in order to address the differences in value and impact 
between inventions. The idea of using patent citations as an indicator is relatively old and 
appears to have originated from Seidel in 1949  (Karki 1997). However, the first systematic 
empirical investigations only emerged in the 1980’s, with Carpenter et al. (1981) showing that 
patents related to industry awards are cited more frequently.  
A patent can be cited for various reasons: an inventive step, its industrial relevance, to 
qualify novelty, or to provide additional, relevant information to situate the claims advanced in 
the patent document. Patents that are cited (more often) are considered more important and 
valuable than patents that are not used (or used infrequently) to qualify subsequent technological 
activity. Therefore, one can approximate an individual patent’s importance by the number of 
times it is cited. This argument is empirically supported by the work of Trajtenberg (1990) and 
Gambardella et al. (2008) who show that patent citations correlate significantly with the value of 
the individual patent. Likewise, Hall et al. (2005), Narin and Noma (1987) and Neuhäusler et al. 
(2011) find a positive correlation between firm performance and the total number of forward 
citations that their patents receive, even after correcting for firm size. Lanjouw and Schankerman 
(2004) have determined that patent citations are correlated with other indicators of patent quality, 
which in turn are correlated with variations in firm value. Additionally, Neuhäusler and Fritsch 
(2012) and Fritsch et al. (2014)  show that forward patent citation counts are strongly correlated 
with export volume. 
                                                 
2 Often referred to as patent citations, forward citations or patent citation count. We will use these terms throughout this 
paper. 
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While (front page) patent references are ultimately included by examiners, a number of 
researchers conceive citations as an approximation of knowledge flows: (Hall et al. 2005; Jaffe et 
al. 1993,2000; Mcgarvie 2006; Paci and Usai 2009). When this perspective is adopted, the 
number of patent citations received indicates the subsequent influence or impact of the 
knowledge implied in the patented invention.  
A major advantage of using patent citations as an indicator of inventive quality, either 
conceived as value or impact,  pertains to the relative simplicity of the measure: it merely 
requires counting the number of citations a patent receives. Since a large number of patents 
receive citations3, this measure allows for the construction of enriched indicators both on the 
patent level and on more aggregate levels (e.g. firm, industry, country).  Currently, patent 
citations are considered an important indicator of the innovative output of companies (e.g. 
Hagedoorn and Cloodt 2003). They also enable statistics and rankings that can be used to 
determine the innovative performance of countries (e.g. Chakrabarti 1991; Criscuolo and 
Verspagen, 2008; Neuhäusler and Fritsch, 2012). 
While these, and related studies, point to the relevance of counting the citations received 
by patent documents, the method of measuring this count is not singularly defined.  
Despite the simple conceptualization of the measure, calculating citation indicators 
involves a number of methodological decisions that, in turn, result in a variety of possible 
citation indicators. The first decision is to choose the data source from which to compile patent 
citations, given that patent systems are geographically bounded (e.g. US, EU, Japan, China). 
Since patent citations to one patent system can stem from different geographic areas, the second 
decision is to choose the source from which citations to the focal set of patents will be included. 
Finally, given the possible existence of multiple patent documents pertaining to a single 
                                                 
3 Up to 88% of applications score a non-zero citation count on at least one of the citation indicators we computed.   
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invention, a viable option is to treat equivalent patent documents as one patent family, which will 
also affect citation counts. Currently, there are three different approaches to these decisions in 
the literature. 
The National Bureau of Economic Research (NBER) set up a data platform that contains 
only patents filed at the United States Patent and Trademark Office (USPTO). This data has been 
available as early as 2001 (Hall et al. 2001). Additionally, the first analyses on patent citations 
relied on data from USPTO documents (e.g. Carpenter et al. 1981; Narin and Noma, 1987).  The 
NBER database is still widely used as the high number of recent citations to the source paper 
from Hall et al. (2001)4 attests.  
A second set of studies has been conducted using European Patent Office (EPO) patent 
documents. European patent data is noticeably different from USPTO data: the EPO patents 
cover a different geographic area; they are heterogeneous in terms of the countries where they 
are filed; and finally, examiners tend to include fewer citations than their colleagues from the 
USPTO. Citation data from EPO patents have been compiled since 2003 (Webb et al. 2005) 
resulting in several EPO-based patent citations studies (e.g. Harhoff and Reitzig 2004; 
Neuhäusler et al. 2011; Schoenmakers and Duysters 2010).         
Finally, some researchers have opted to go beyond the use of data stemming from a 
single source (patent office) and take into account the presence of patent families (hence, 
considering the equivalents of an invention that are present in multiple patent systems when 
calculating citations). This seems especially appropriate in correcting for ‘home biases’ 
(Criscuolo 2006) and in providing a more encompassing view of the impact of an invention. 
Examples of this approach can be found in the work of Gambardella et al. (2008), Graham and 
Harhoff (2006), Magerman et al. (2011), and Neuhäusler and Fritsch (2012). 
                                                 
4 This paper needs to be cited when the NBER database is used. 
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When using a patent citation indicator, it is implicitly assumed that different calculation 
methods of this indicator will, in general, yield similar results.  However, this may not 
necessarily be the case: patent citations from different offices may reflect ‘national’ impact 
rather than ‘global’ impact. Additionally, patent offices focus on their own geographical 
jurisdiction, which may result in a ‘home bias’ when looking at patent citations (Criscuolo 2006). 
Finally, offices and, hence, examiners’ practices vary in terms of the average number of patent 
citations included: USPTO patent documents display (on average) more citations than EPO 
patent documents. This, in turn, can lead to a situation whereby citation indicators – derived from 
different computational choices – do not reflect the same information (Alcácer and Gittelman 
2006). For these reasons, it makes sense to assess the effects of the methodological choices that 
researchers face when assessing patent quality through forward citations. To the best of our 
knowledge, no systematic analysis of this kind has been performed. This paper will assess the 
extent to which different methods yield (dis)similar results. Hence, we pose our research 
question as follows: 
Do citation counts that are computed by different methods reveal similar information?  
  
This question can be further refined by adopting the distinction between technological 
improvements of an incremental nature vis-à-vis  inventions implying a more radical departure 
from what was previously possible (Baumol 2004; Dosi 1982). Accordingly, researchers have 
operationalized these ‘breakthrough’ inventions by identifying patents receiving exceptionally 
high numbers of forward citations (e.g. Ahuja and Lampert 2001, Chakrabarti 1991; 
Schoenmakers and Duysters, 2010). Since citation counts may depend on computational choices, 
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it is of particular interest to compare different methods with respect to identifying highly cited 
patents.  This leads to the following extension of the research question: 
To what extent do different calculation methods affect the identification of highly cited 
patents? 
 
In the remainder of this paper, we answer our first question using correlation and cluster 
analyses, which compare different methods to calculate citation counts of patent applications. To 
answer the second research question, we compute the degree of overlap observed between 
patents that are identified as  highly cited  by various methods. We start with a systematic 
discussion of the different computational choices, resulting in a set of indicators that this study 
then compares. We then present the empirical findings that we obtained and discuss their 
implications. Overall, our findings signal non-trivial differences among the variety of approaches 
envisaged.  
OVERVIEW OF THE METHODOLOGICAL CHOICES WHEN COMPUTING  
PATENT CITATION INDICATORS 
When counting patent citations, different choices need to be made. These choices pertain 
to the patent system (or protocol) in which the receiving and citing patent documents reside. The 
presence of patent families could also be taken into account. In this section, we discuss the 
general choices that are available when counting forward citations.  
The patent office  
The patent system in which the patent resides may affect the way in which the patent is 
cited. This is due to two reasons: the home bias and the inherent difference between the patent 
systems. A home bias, as discussed in the introduction, implies that patent examiners cite more 
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prior art present in their own jurisdiction5 (Michel and Bettels 2001). In addition, while patent 
systems are largely similar in terms of subject matter and application procedures, they 
nonetheless differ in several ways. Not only are there observable differences in terms of subject 
matter – between the USPTO and the EPO concerning the costs incurred (van Pottelsberghe, de 
la Potterie, and François 2009) – but practices such as the ‘duty of candor’6 in the US lead to an 
increase in references being included in patent documents, which may have an impact on 
citation-based indicators.  
Selection of the citing patents 
The second choice a researcher faces relates to selecting the patent documents that cite 
the focal patent. One can choose to count  either the citations that an entity (application or patent 
family) receives from patents in the same patent office (e.g. EPO, USPTO) or to include citations 
from patents present in other patent systems. The reason this distinction is worth investigating is 
twofold. 
First, we note that many researchers restrict themselves to a single source, which is often 
the EPO or the USPTO system, as noted in the introduction. This implies they only count 
citations that patent applications receive from documents residing in the chosen system. 
Therefore, it is interesting to examine the effects of this restriction: does restricting citations to 
the office of the focal application significantly alter the results?  
Second, most documents tend, largely, to cite patent documents from within their chosen 
‘system’, due to the examining process (Michel and Bettels 2001). This is not unexpected since 
patent examiners should have an overriding concern for the validity of the application within 
                                                 
5 We show this later in Table 4. 
6 The ‘duty of candor’ rule requires that applicant and inventors involved in a patent application must disclose all 
known information which may adversely affect the probability of obtaining a granted patent.  
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their own jurisdiction.  At the same time, when specific procedures are in place, differences can 
become more pronounced. The case of USPTO is apposite in this respect. When applying to the 
USPTO, applicants have a so-called duty of candor, requiring them to disclose to the examiner 
any knowledge of prior art, even if this information could lead to the application being 
disqualified. Patent examiners then select from these references and/or add other references 
deemed relevant. However, USPTO examiners are most familiar with USPTO patents. In the 
case of foreign applicants, references stemming from prior art located outside the American 
patent system may be advanced relatively more frequently by such applicants. Indeed, Sampat 
(2004) observed that, in approximately 70% of patents, references to foreign patents are initially 
advanced by the applicant (see Azagra-Caro et al. 2011 in this respect).      
Correcting for patent families 
Patents that represent and/or build on the same invention can also be grouped into so-
called ‘patent families’. It makes sense to correct citations for the presence of families since 
other patents can make reference to multiple family members besides the initial, focal 
application. If the researcher feels that such a citation is just as valuable as a direct citation of the 
initial patent application, then a correction based on the patent family seems appropriate. In 
general, this involves adding citations from family members to the citation count of the focal 
application itself. A case study by Nakamura et al. (2015) shows that accounting for patent 
families can improve analyses based on patent citations.  
There are different definitions of the patent family: in this paper, we consider two. 
Martinez (2011) defines them as the extended patent family (INPADOC7) and the examiner’s 
                                                 
7 INPADOC is an abbreviation for INternational PAtent DOCumentation, the patent data collected but not generated by 
the EPO (EPO 2014). It is also used to denote the extended patent family in the EPO PATSTAT databases. 
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technology-based family (DOCDB8). The DOCDB definition centers on finding the closest 
equivalents of a patent document in other offices. These documents are usually characterized by 
having the same priority applications.9  The INPADOC definition is less strict and is used to find 
documents protecting the same invention, including documents with a somewhat different 
priority profile (Albrecht et al., 2010). The members of INPADOC patent families share priority 
applications with at least one other member of the family. Therefore, patents that are members of 
the same DOCDB patent family should also be members of the same INPADOC patent family, 
since all DOCDB patent family members have the same priority applications10. However, it is 
possible that two members of the same family share no priority applications. This can occur 
when they both share a priority application with a third member of the family (Lingua, 2005). In 
this study, both family definitions will be adopted and assessed.   
 
 
 
  
                                                 
8 DOCDB is the EPO master documentation database (Martinez 2011). It is also used to denote the examiner’s 
technology-based patent family in the EPO PATSTAT databases. 
9 Albrecht et al. (2010) define the DOCDB patent family as patent applications that have an equal ‘priority picture’: this 
can, under certain circumstances, include the priority application itself. Additionally, this family is corrected to include 
applications that have the same technical content but have been excluded due to a ‘discrepancy in the priority picture’ Albrecht et 
al (2010: 283) .  
10 This statement holds for the vast majority of patent applications in the EPO PATSTAT database; there is a small 
minority of patents (0.09% of DOCDB patent families) that do not fulfill this criterion due to discrepancies in their priority 
picture. However, these families do not affect the analyses presented later in this paper. 
11 
 
DATA AND METHODS 
Data used 
We used patent data from the October 2011 version of the EPO PATSTAT database. 
From this data, we extracted indicators for patent applications belonging to the EPO and the 
USPTO, as well as applications that were filed through the Patent Cooperation Treaty (PCT) 
route. We chose these applications for three reasons: First, most research that employs patent 
citation data uses patents from at least one of these three systems (or routes, in the case of PCT 
applications). Second, the data provided by these offices from the USPTO and the EPO is 
relatively complete in PATSTAT, compared to other offices (also included in PATSTAT). In the 
remainder of this paper, we shall refer to different origins by designating documents as EPO, 
USPTO and PCT patent applications. 
The focal applications for which the indicators were calculated have been cleaned to 
remove – amongst others – duplicates caused by untraceable priorities and citations, incorrect 
conversions of patent numbers, and several issues caused by changes in the USPTO system in 
200111. In addition, we only considered USPTO applications that were granted. This is due to the 
observation that USPTO applications that did not lead to a granted patent are not completely 
covered by PATSTAT.  
After the cleaning exercise, we were left with 8,658,272 focal applications from which 
4,397,304 were applications filed at USPTO,  2,343,707 applications filed at EPO and 1,917,261 
applications filed via the PCT route. The filing dates range from the 2nd of January, 1970 to the 
6th of May 2011.  However, it should be noted that the cleaning activity led to the removal of a 
large number of applications: 3,319,894 applications from the USPTO (mainly because no 
                                                 
11 These imply changes in publication types; patent duplicates that occur before and after 2001; and applications that 
are not available before 2001 but partly available thereafter.  
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granted equivalent was yet present); 10,567 applications from the EPO, and 11,335 PCT 
applications. 
With regard to the citing applications, we used all patent documents available in the 2011 
October version of PATSTAT. We excluded only artificial applications12. Therefore, the cited 
applications involved more cleaning than the citing applications. This was carried out because 
we wanted to keep the citation indicators as close as possible to those obtained when using 
currently available databases (notably PATSTAT). Consequently, we did not correct all recently 
known issues that exist in patent citation indicators.13  
The patent citation indicators and their definitions 
 We performed four different permutations to calculate our indicators. These are based on 
patent origin, citation origin and a twofold family correction (see previous section). We have 
chosen these permutations in the belief that they represent virtually all possible permutations that 
researchers are likely to consider when working with patent citations. In this section, we explain 
how these permutations are used. 
Starting with patent origin, we compare indicators resulting from three different data 
sources: EPO, USPTO, and applications filed through the PCT route. We use this data because 
the vast majority of publications dealing with patent citations use indicators drawn from these 
sources. Next, we distinguish two groups of indicators based on the source of the citation. This is 
done by comparing the number of citations received from applications in the office of the focal 
application, and the number of citations that were received irrespective of the patent office14. We 
                                                 
12 These are added to the database to maintain logical links and do not actually represent any patent applications.  
13 An example of this pertains to the well-known issue that EPO references other patents by referring to the references  
of  their PCT equivalents via a non-patent reference in PATSTAT. This has been noted in Harhoff (2006) and Neuhausler et 
al.(2011).  
14 In the case of applications filed through the PCT, other applications that followed this route were taken.  
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will denote those indicators with a restricted source of citations by adding ‘within office’ to the 
indicator name.   
A third permutation deals with applying a correction for citations received by family 
members of the focal application. Each family indicator is, therefore, replicated for each patent 
office. For the patent family definition, we compare both the INPADOC and DOCDB 
definitions. We denote patent citation indicators that correct for patent family on the cited side 
(i.e. an indicator that counts all applications that cite the family of the application) by including 
‘cited family count’ in their name.  
It is possible that a number of citations originate from applications that are part of the 
same patent family. It can be argued that these citations are mere duplicates since the patent is 
cited twice by the same invention. This could then create a bias towards citations received from 
larger patent families, since it is inherent that the size of the family increases the probability of 
two or more of its members citing the same patent.  Therefore, as a final, fourth  permutation, we 
correct for this bias by counting not the number of patent applications but rather the number of 
patent families that cite the focal family.  We denote patent citation indicators that have this 
correction by replacing ‘cited family count’ with ‘full family count’ in their name. Table 1 
provides an overview of the prefixes for the indicators used in this paper 
------------------------------- 
Insert Table 1 about here 
------------------------------- 
  
This leads to a total of ten different indicators for each office: two indicators based on the 
application, four indicators based on the DOCDB family and four indicators based on the 
INPADOC family. To keep the list of indicators tractable, we provide names and definitions for 
each indicator in Table 2.   
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------------------------------- 
Insert Table 2 about here 
------------------------------- 
 
We computed descriptive statistics for the indicators in Table 2; these are listed in Table 
3. From these descriptive statistics, we can derive two main conclusions.  The first is that a large 
number of patents receive at least one citation. However, the rate of patents with a non-zero 
citation count varies considerably, from 25% (EPO application count within office) to 88% 
(USPTO INPADOC full family count and USPTO INPADOC cited family count). Therefore, the 
distribution of the citation indicator varies from highly truncated to a more continuous spectrum. 
Second, we observe that the indicators vary greatly with respect to their averages and standard 
deviations. The average of the EPO application count within office is about 45 times smaller than 
the average of the USPTO INPADOC cited family count.  
------------------------------- 
Insert Table 3 about here 
------------------------------- 
 
To perform the correlation analysis of the citation indicators, we use only applications 
that receive at least one citation for any of the indicators considered. In practice, this definition 
translates into selecting only those applications that receive at least one citation on the  DOCDB 
level or the INPADOC family level. Consequently, other indicators can still have a score of 0. 
This was done in order to better assess the information contained in the citation counts.  Its 
effects are quite substantial since – depending on the office15 – a considerable share of patents in 
our sample have no citations, resulting in identical scores (0) for all indicators. The inclusion of 
applications that are never cited would have an inflating effect on the correlation and is, 
therefore, undesirable. 
                                                 
15 The exact figures are: 21% for EPO applications, 12% for USPTO applications and 37% for PCT applications. 
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The distribution of citations 
To better understand the behavior of the patent citation indicators, we compiled an 
overview of the origin and destination of citations,  shown in Table 4. This table reveals that the 
USPTO is the main supplier of citations in the patent system. Not only does the vast majority of 
citations to USPTO entities come from the USPTO itself but the USPTO also supplies most 
citations to other documents. There are more USPTO citations to EPO documents than EPO 
citations to USPTO documents. A similar pattern emerges for PCT documents.  
Correcting for patent family remedies this to some extent; at the same time,  USPTO 
documents remain dominant since they account for the most citations overall. In the case of the 
EPO, INPADOC families with an EPO member receive 6.4 times more citations from USPTO 
documents than from EPO documents.   
Note that the large majority of all citations stem from either USPTO, EPO or PCT 
documents; very few citations come from other offices such as the Japanese Patent Office (JPO) 
or the Chinese Patent Office (SIPO). It is interesting to observe that, from the remaining 
citations, the vast majority are from applications at the national level of the EPO. These citations 
may indeed represent a duplication of EPO patents, or they may be applications that were filed at 
only a single national office instead of the EPO, due to the costs of the EPO process (as noted by 
van Pottelsberghe, de la Potterie and François (2009)).      
------------------------------- 
Insert Table 4 about here 
------------------------------- 
Patent families 
In this paper, we deploy two different family definitions: the DOCDB and the INPADOC 
definitions. We have compiled some descriptive statistics to understand the effects of correcting 
for patent family. These statistics are shown in Table 5. Here, we can see that a large number of 
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patent families exist in the database. Note that, even though these families need at least one EPO, 
USPTO or PCT application, they may also have applications from other offices.  
From these patent families, only between 21% and 35% consist of a single patent 
application. Most patent families have at least two or more members.  Finally, we see that a large 
number of patent families are equal for either family definition, even after excluding singleton 
families, which are equal by definition.  
------------------------------- 
Insert Table 5 about here 
------------------------------- 
RESULTS OF THE CORRELATION ANALYSIS 
The effects of expanding the sources of citing patents and correcting for patent family 
We first determined the effect of correcting for family and citation origin for each office 
separately. For this purpose, we compared the ‘application count within office’ indicator with all 
other indicators in the office of the focal application. This was done for two reasons: First, the 
indicator is the most basic (i.e. it is uncorrected for family and only uses citations from its own 
office). Second, it is the indicator that is most widely used: the NBER citation indicator is the 
USPTO ‘application count within office’, while the aforementioned scholars who utilize EPO 
data often use the EPO ‘application count within office’.  The results of this exercise are 
presented in Table 6. The full correlation table can be found in Appendix A.   
------------------------------- 
Insert Table 6 about here 
------------------------------- 
Table 6 shows that there is a substantial effect of citation origin (i.e. all citations versus 
only those from within the office) on the patent citation indicators.  This can be seen when 
inspecting the correlation of the ‘application count within office’ indicator with the ‘application 
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count indicator’. This effect is more pronounced for EPO and PCT indicators, with correlations 
of 0.77-0.79, than for their USPTO equivalent, which is less sensitive in this respect (see the 
correlation of 0.99). Given the citation information presented in Table 4, this should come as no 
surprise. 
Correcting for patent family introduces considerable differences. The effects of this 
correction are more outspoken in the EPO and PCT systems than in the USPTO system: where 
the USPTO ‘application count within office’ has a correlation of 0.84 with the DOCDB family-
corrected indicator, the equivalent correlations for EPO and PCT are situated around 0.33. 
Correcting for the INPADOC patent family has an even stronger effect than correcting for the 
DOCDB patent family.  Finally, we see that correcting for patent family on the citing side has a 
relatively small effect. The values in Table 6 are almost equal for the cited family count and the 
full family count indicators. The tables in Appendix A confirm this conclusion: the correlations 
between cited family count and full family count indicators are very close to 1 for both the 
DOCDB and the INPADOC family definitions.      
The effect of using different sources (for patent  documents present in all three systems)  
For an inter-office comparison, we calculated the correlation for DOCDB patent families 
from which applications were filed at the EPO, the USPTO, and through the PCT route. This was 
done because the DOCDB family is based on the technical equivalence of the documents. 
Therefore, we can assume that the different elements in the DOCDB family are documents 
describing the exact same invention in different jurisdictions. Because of this equivalence, a 
direct comparison focusing on the source document is feasible.  
Again, we considered only patents that had at least one citation in their largest (i.e. 
INPADOC) family. However, we found that all DOCDB patent families with applications in all 
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three offices fulfilled this criterion. Therefore, this restriction did not change the analysis. These 
considerations led to the comparison of citation indicators for 388,512 DOCDB families. The 
full correlation matrix is presented in Appendix B. Here, we extracted the correlations that 
compare the different sources of patent data. These are listed in Table 7.  
------------------------------- 
Insert Table 7 about here 
------------------------------- 
 
Table 7 shows that correlations for the basic indicators obtained for the same family but 
derived from relying on different offices are very low. The correlation between the EPO 
‘application count within office’ and the USPTO ‘application count within office’ is only 0.09. 
Using citations from outside the office of the focal application (‘application count’) remedies this 
slightly by raising the correlation to levels ranging from 0.11 to 0.30.    
Correlations observed when correcting for the DOCDB and INPADOC families are 
considerably higher. This is naturally the case for the DOCDB cited family count and the 
DOCDB full family count since the applications are all part of the same family. The INPADOC 
cited family count and the INPADOC full family count indicators also have coefficients of 1, as 
shown in Table 7. This is due to the fact that applications that are members of the same DOCDB 
family are also members of the same INPADOC family. Interestingly, correcting for patent 
family increases compatibility, even when only citations from the office of the focal application 
are counted. Therefore, even when there is only application data from one patent office, 
correcting for the patent family of the focal applications is an interesting method for increasing 
compatibility with data from other patent offices.  
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Clustering the patent citation indicators 
We performed a cluster analysis on the patent citation indicators by using the correlation 
table listed in Appendix B, i.e. pertaining to patent documents that have equivalents in all 
different systems under study.  To define clusters,  we performed a divisive cluster analysis, 
based on factor analysis (see Appendix C for a technical description).  Since the analysis 
compares patent applications with the counterparts of their DOCDB patent family, the indicators 
‘DOCDB cited family count’ and the ‘DOCDB full family count’ give equal values regardless of 
the office of the focal application. Therefore, they are replaced by the general indicator. This is 
also carried out for the corresponding INPADOC family indicators since DOCDB family 
members are also part of the same INPADOC family: the INPADOC family is by definition 
larger. Including all INPADOC indicators would thus be redundant. The resulting indicators are 
denoted by the  ‘ALL’ notation. The identified clusters are reported in Table 8.  
------------------------------- 
Insert Table 8 about here 
------------------------------- 
We have created a graphical depiction of the variables and their relation to one another 
using multidimensional scaling. The result is shown in Figure 1. The cluster analysis shows that 
citation indicators that are from different offices (the ‘application count’ indicators) are 
significantly different:  the corresponding USPTO, EPO and PCT indicators are all grouped into 
different clusters. This indicates that, when using indicators from USPTO, EPO and PCT sources 
only, one is relying on different information.  
Correcting for patent family substantially increases compatibility. The indicators that are 
based on the DOCDB family are grouped into only two clusters (clusters DOCDB A and 
DOCDB B) that appear close to each other (see Figure 1). It is interesting to note that the 
USPTO DOCDB family indicators are clustered together with the overall family indicators. This 
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is understandable given the large number of citations that originate from the USPTO system. 
Finally, we see that the INPADOC indicators are all grouped together in one cluster (cluster 
INPADOC). Therefore, we conclude that correcting for the INPADOC patent family results in 
more similar information across patent systems. 
------------------------------- 
Insert Figure 1 about here 
------------------------------- 
Robustness tests 
We performed several robustness tests to verify the results of the correlation analysis 
under different assumptions and settings. These tests were performed both on the level of the 
individual sources of the applications (EPO, USPTO and PCT) and the combined set, unless 
otherwise indicated.   
Using a full factor analysis. We performed a full factor analysis on the indicators. We 
used the principal component method and rotated the solution using the Quartimax algorithm, 
since this is the most capable method of assigning indicators to different factors. This led to five 
factors with an eigenvalue larger than 1. We grouped indicators that had loadings higher than 
0.5. on the same factor. This analysis resulted in similar conclusions to the cluster analysis: all 
indicators that relate to patent applications are grouped according to office. However, the family 
indicators were grouped differently: there was one factor that had all family related indicators, 
with the exception of the EPO and the PCT DOCDB indicators, which were grouped separately. 
Thus, a factor analysis groups clusters 1 and 6. We can, therefore,  derive the same conclusions 
as in the cluster analysis: patent citation indicators that relate to equal applications are different 
from each other, especially when they are related to applications from different patent offices. 
Family indicators are more similar, but the difference between DOCDB and INPADOC 
indicators remains present.     
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Inclusion of uncited applications. In our main analysis, we excluded patent applications 
that had zero citations on any indicator. This was carried out in order to improve the precision of 
the analysis. When we included the uncited applications, we found that the correlation of the 
different indicators increased slightly. However, this increase was small and equally distributed 
across the different correlation coefficients between the citation indicators. Consequently, we 
conclude that the inclusion of applications with zero citations does not substantially change the 
conclusions of the preceding section. 
Using only granted applications. The main analysis of the paper pooled different kinds 
of patent application. It could be that the citation patterns of applications leading to a grant are  
different from those of other applications. Since granted patent applications are more valuable, 
researchers could opt to use only those in their analysis. Hence, it is important to determine if our 
results hold when only considering granted applications. 
Patent applications that follow the PCT route cannot be granted (as PCT documents), 
since the WO is not a patent office with a territory over which it exercises patent grants. Since 
we only used granted patent applications from the USPTO, the USPTO indicators will not be 
affected by this step. Therefore, the analysis will only affect the EPO patent applications. For the 
overall analysis, we included the PCT and USPTO documents to derive a close comparison with 
the main analysis. 
Using only granted applications from the EPO does not substantially change the 
correlation between the different indicators. Correlations between indicators on EPO and USPTO 
documents varied little with the main analysis. This then resulted in the same clusters being 
returned by the cluster analysis. Nor were the inter-office correlations substantially different. 
Thus, we conclude that our findings remain similar when including only granted applications.   
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Using log citations instead of normal citations. Many researchers include not the raw 
patent citation count but rather the logarithm of the citation count to account for the skewed 
distribution of patent citations. Therefore, we have also computed the indicators using the 
following transformation:  
𝐼𝐼∗ = ln(𝐼𝐼 + 1)  
Whereby I is any of our citation indicators and I* is its transformed form.  We have 
computed correlations between all transformed indicators.  
This transformation yields indicators that are more similar to each other.  This is because 
the difference between low and extremely high scores is diminished. Hence, all correlations are 
substantially improved. This leads the clustering algorithm to select fewer groups. In particular, 
all DOCDB indicators are now grouped together. All other groups are equal. So, we conclude 
that, even though the log transformation improves the correlations, this improvement is not 
sufficient to remove any significant differences that we found in the main analysis.    
Using only patent data from before 2000. The main analysis was performed on patent 
data that cover the time period 1980-2011. Consequently, there are numerous patents that have 
not yet received (all of their) citations. Since different patent systems may well experience 
different time lags, this could create a difference in citation data that is due to these time lags, as 
opposed to an inherent difference in information. In order to control for a potential time lag 
effect, we repeated the correlation analysis using only patent applications that were filed before 
2000. For our complete analysis, we only compared patent families from which at least one 
patent in each office had a filing date before 2000.  
We find that indicators for patents filed before 2000 behave in a similar, albeit not 
identical, way to the main analysis. The major difference is that the correlations between family-
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based indicators, most notably those based on INPADOC, increase substantially. This was most 
pronounced when we computed the full correlation matrix over the three sources of patent data. 
Because of this, the cluster solution was altered with a reduced number of clusters: one large 
cluster with all family based indicators, thereby combining clusters INPADOC, DOCDB A and 
DOCDB B from the main analysis; and three small clusters with application counts from each 
office, equal to clusters EPO, USPTO and PCT from the main analysis. Consequently, we can 
conclude that family-based indicators are more similar in this sample, while non-family-based 
indicators remain very different from each other and from the family-based indicators.  
HIGHLY CITED PATENTS  
Set-up of the analysis 
We identified the groups of highly cited patents according to two different criteria: the 
top 100 patents in terms of citations received, and patents that score more than 5 standard 
deviations (sd.) above the mean number of citations of all patents under study16. Highly cited 
patents were identified, reflecting the unit of analysis of the respective indicators (patent 
application , DOCDB patent family, INPADOC patent family).  
The effects of expanding the sources of citing patents and correcting for patent family 
The main observation from the analysis is that commonality between sets of highly cited 
patents, identified via different indicators, is rather low, whether one considers the top 100 cited 
patents or patents receiving 5 standard deviations more citation on average.  
Table 9 reports the results obtained in calculating how many identical patent applications  
are identified when adopting different choices with respect to calculating citations. The reference 
                                                 
16 The size of the groups of highly cited patents identified by the 5 sd. outlier criterion varies between 765 and 35,145 
depending on the source office and indicator specification.  
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group consists each time of the patent documents identified by applying the ‘application count 
within office’ indicator: citations to the focal document within the patent system of the focal 
document.  
------------------------------- 
Insert Table 9 about here 
------------------------------- 
From Table 9, we can derive several conclusions: First, we observe that 5 standard 
deviation outliers of  indicators are in general more similar than the top 100 scores. Second, the 
table resembles the pattern in Table 8: we observe low levels of overlap for EPO and PCT 
documents while, for USPTO documents, the overlap is consistently higher. Third, we again 
observe that both the correction for citation origin and the correction for family have a 
considerable effect on the indicators. In the case of the EPO and the PCT, we find that the 
patents identified in the top 100 of the ‘application count within office’ indicator and those 
identified by the family corrected indicators hardly overlap. 
Even though the commonality improves for the 5 sd. outlier and for the USPTO 
indicators, we conclude that the differences are non-trivial. Differences are larger for INPADOC 
than for DOCDB indicators.  
The effect of using different sources of patent data  
In this analysis, we focused on comparing similar indicators from each office with each 
other. Table 10 presents the result of this analysis. It is important to note that there are two 
mechanisms by which a highly cited patent does not appear in another patent system. It could be 
because its family members did not receive a sufficient number of citations, or because it did not 
have family members present in the other patent system.  
------------------------------- 
Insert Table 10 about here 
------------------------------- 
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In concordance with the results from the previous analysis, we see that using the top 100 
rank criterion results in a similar overlap pattern as using the 5 sd. outlier criterion. However, the 
qualified overlap scores are generally lower when using the top 100 rank criterion. Overlaps 
between indicators that score applications on the citations they receive from within their own 
offices are very low. This is only slightly improved when citations from other offices are 
included (moving from ‘application count within office’ to ‘application count’ yields, at best, an 
increase of 3% for the top 100).   
The use of citation indicators that correct for families drastically increases overlap scores 
between offices. While the use of DOCDB corrected indicators results in qualified overlaps of 
around 50%, the highest overlap scores are obtained when INPADOC family corrected citation 
indicators, which use all citations, are used.  
CONCLUSION 
We set out to determine the (dis)similarity between different citation indicators. We 
achieved this by computing a set of commonly and less commonly used citation indicators and 
comparing them with one another. We relied on correlation and cluster analysis to assess 
(dis)similarities; in addition, we examined which highly cited patents were identified by different 
indicators. The results showed substantial dissimilarities between the various patent citation 
indicators. 
The correlation and cluster analysis demonstrated that there are large differences in the 
information revealed by patent citations, depending on which indicator is used. First, a 
significant effect was present when comparing indicators that use citation information from all 
offices versus indicators that only use ‘within office’ citations. Second, indicators computed over 
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different entities (patent application, DOCDB patent family, INPADOC patent family) display 
only modest levels of commonality. Finally, these effects are most pronounced for EPO and PCT 
patents. The USPTO indicators tend to be more similar, except when the INPADOC family is 
corrected for. 
Cluster analysis revealed distinctive clusters for each office. Most family corrected 
indicators, whether they encompass all citations or not, were grouped in clusters reflecting the 
family definition. Only the indicators based on the DOCDB patent family definition were split 
into two clusters. Therefore, we conclude that patent citation indicators based on families are 
more comparable to each other, even when information from only one office is used. This 
conclusion remains robust under all tests that were performed. 
The analysis of highly cited patents provides a similar picture.  Correction for the family 
and the citation origin results in significant effects and leads to larger commonality between 
different indicators. Commonality is higher when adhering to the indicator reflecting ‘5 standard 
deviation’ outliers compared to relying on the indicator consisting of the 100 most cited patents. 
The only indicator resulting in  almost complete congruence pertains to the INPADOC corrected 
indicators.  
Since this paper has established clear differences between different citation indicators, it 
may inspire additional research on the underlying drivers of these differences. Future efforts 
should be made to examine the origins of these differences. Are they fully explained by different 
practices in the different offices or do they indicate a separated impact from the regions over 
which these offices grant patents? A similar effort should be focused on the family indicators. 
While it appears that they give unbiased information of the global impact of an innovation, this 
may not be completely true: Family indicators correlate more with USPTO indicators than with 
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their EPO or PCT counterparts.  We suggest that this could be due to the higher number of 
citations that are present in the USPTO system, thus biasing the family indicators towards the 
greater importance of citation activity in the US. Therefore, efforts could be undertaken to 
examine the magnitude of this possible bias and, if necessary, derive an unbiased global patent 
citation indicator.  Finally, the INPADOC patent family definition could be further investigated: 
while the DOCDB definition is clear and often used, this is not the case for the INPADOC patent 
family definition.  
The observation that different indicators display low levels of commonality implies that 
choices with respect to citation indicators are non-trivial. As a result, we suggest researchers 
become more aware and explicit in deciding which citation indicator to use. This choice should 
be ultimately be guided by the underlying research question. At the same time, our results may 
also inspire further research into assessing the consistency of results obtained when deploying 
different citation indicators. If the intention is to strive for an indicator that is not sensitive to 
design choices, the INPADOC corrected indicator is clearly the prime candidate since it implies 
commonality approaching 100%. 
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APPENDIX A: CORRELATION BETWEEN INDICATORS FROM THE SAME 
OFFICE 
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APPENDIX C: VARIABLE CLUSTER METHOD 
This appendix explains the cluster algorithm that was used to cluster indicators. This 
method is an implementation of the VARCLUS procedure in the SAS® software package (SAS 
Institute, 2009). What follows are excerpts from the SAS manual (SAS Institute, 2009: 7461-
7463) explaining the logic of the  underlying procedure. Our specific settings are detailed in 
italics. Options not related to our analysis have been omitted.  
‘The VARCLUS procedure divides a set of numeric variables into disjoint or hierarchical 
clusters. Associated with each cluster is a linear combination of the variables in the cluster. The 
linear combination used here consists of  the first principal component. (…) The first principal 
component is a weighted average of the variables that explains as much variance as possible.  
(…) 
The VARCLUS  procedure tries to maximize the variance that is explained by the cluster 
components, summed over all the clusters. The cluster components are oblique, not orthogonal, 
even when the cluster components are first principal components. In an ordinary principal 
component analysis, all components are computed from the same variables, and the first 
principal component is orthogonal to the second principal component and to every other 
principal component. In the VARCLUS procedure, each cluster component is computed from a 
different set of variables than all the other cluster components. The first principal component of 
one cluster might be correlated with the first principal component of another cluster. Hence, the 
VARCLUS algorithm is a type of oblique component analysis.  
We use the correlation matrices as input for the principal component analysis used in the 
VARCLUS procedure (…) 
33 
 
The VARCLUS algorithm is both divisive and iterative. By default, the VARCLUS 
procedure begins with all variables in a single cluster. It then repeats the following steps: 
1. A cluster is chosen for splitting. Depending on (...) the largest eigenvalue associated 
with the second principal component (…) 
2. The chosen cluster is split into two clusters by finding the first two principal 
components, performing an orthoblique rotation (raw quartimax rotation on the 
eigenvectors; Harris and Kaiser 1964), and assigning each variable to the rotated 
component with which it has the higher squared correlation. 
3. Variables are iteratively reassigned to clusters to try to maximize the variance 
accounted for by the cluster components.  
 
(…)VARCLUS stops splitting when every cluster has only one eigenvalue greater than 
one, thus satisfying the most popular criterion for determining the sufficiency of a single 
underlying dimension.’ 
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FIGURES  
Figure 1: Depiction of the differences between citation indicators on a 2D plane by 
multidimensional scaling. The dissimilarity between indicators, as defined by 1-R2, is 
represented by the distance between them. Cluster names are related to clusters as described in 
Table 8. 
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TABLES 
Table 1: Simplified table of naming indicators. All indicator names consist of a number of 
prefixes and the word count. This table explains the origins of each prefix.  Full definitions for 
each indicator can be found in table 2.   
 
The origin of 
the prefix 
Office of 
the focal 
patent 
Application or 
patent family  
If patent family 
correction only applied 
on the cited side. 
If patent family 
correction applied on 
both sides. 
If only citations from the 
office of the focal patent 
are used. 
Possible 
prefixes 
EPO 
USPTO 
PCT 
Application 
DOCDB   
INPADOC 
Cited Family  Full Family  Within office 
 
 
Table 2: Indicators and their definitions. These indicators are calculated for focal applications 
at the EPO, USPTO and PCT. 
Patent 
Family 
Patent citation 
indicator 
Definition 
N/A Application count Number of citations a patent application receives from all other patent applications, irrespective of their publication office.  
N/A Application count within office  
Number of citations a patent application receives from patent applications that were 
published in the same office as the focal application. 
DOCDB Cited family count Number of citations the DOCDB patent family of the focal application receives from all other patent applications, irrespective of publication office. 
DOCDB Cited family count within office 
Number of citations the DOCDB patent family of the focal application receives from 
patent applications that were published in the same office as the focal application.  
DOCDB Full family count Number of citations the DOCDB patent family of the focal patent receives from all other DOCDB patent families, irrespective of publication office. 
DOCDB Full family count within office 
Number of citations the DOCDB patent family of the focal patent receives from patent 
applications that were published in the same office as the focal application. This count 
is corrected for DOCDB patent family on the citing side. 
INPADOC Cited family count Number of citations the INPADOC patent family of the focal application receives from all other applications, irrespective of publication office. 
INPADOC Cited family count within office 
Number of citations the INPADOC patent family of the focal application receives 
from other patent applications that were published in the same office as the focal 
application. 
INPADOC Full family count Number of citations the INPADOC patent family of the focal patent receives from all other INPADOC patent families, irrespective of publication office. 
INPADOC Full family count within office 
Number of citations the INPADOC patent family of the focal patent receives from 
other patent applications that were published in the same office as the focal 
application. This count is corrected for INPADOC patent family on the citing side. 
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Table 3: Descriptive statistics for the indicators that were computed for this paper 
Focal 
patent 
source 
Patent 
Family 
Patent citation 
Indicator 
Number of 
observations 
Forward citation statistics 
Average Standard 
deviation 
Median  Nonzero  
EPO N/A Application count 2,343,707 1.92 5.10 0 38% 
EPO N/A 
Application count 
within office 
2,343,707 0.57 1.55 0 25% 
EPO DOCDB Cited family count 2,343,707 9.03 20.88 3 75% 
EPO DOCDB 
Cited family count 
within office 
2,343,707 1.07 2.51 0 41% 
EPO DOCDB Full family count 2,343,707 7.28 16.21 3 75% 
EPO DOCDB 
Full family count within 
office 
2,343,707 1.03 2.33 0 41% 
EPO INPADOC Cited family count 2,343,707 17.05 84.56 4 79% 
EPO INPADOC 
Cited family count 
within office 
2,343,707 1.76 8.37 0 45% 
EPO INPADOC Full family count 2,343,707 11.21 47.77 3 79% 
EPO INPADOC 
Full family count within 
office 
2,343,707 1.58 6.43 0 45% 
USPTO N/A Application count 4,397,304 9.91 18.22 5 82% 
USPTO N/A 
Application count 
within office 
4,397,304 8.46 16.35 4 79% 
USPTO DOCDB Cited family count 4,397,304 13.05 24.66 6 86% 
USPTO DOCDB 
Cited family count 
within office 
4,397,304 10.20 21.08 5 82% 
USPTO DOCDB Full family count 4,397,304 10.85 19.48 6 86% 
USPTO DOCDB 
Full family count within 
office 
4,397,304 8.97 17.31 4 82% 
USPTO INPADOC Cited family count 4,397,304 25.95 129.50 8 88% 
USPTO INPADOC 
Cited family count 
within office 
4,397,304 19.73 102.23 6 84% 
USPTO INPADOC Full family count 4,397,304 16.95 72.90 6 88% 
USPTO INPADOC 
Full family count within 
office 
4,397,304 13.54 58.94 5 84% 
PCT N/A Application count 1,917,261 1.90 5.63 0 41% 
PCT N/A 
Application count 
within office 
1,917,261 0.58 1.55 0 27% 
PCT DOCDB Cited family count 1,917,261 5.73 16.38 1 59% 
PCT DOCDB 
Cited family count 
within office 
1,917,261 1.10 2.49 0 41% 
PCT DOCDB Full family count 1,917,261 4.63 12.73 1 59% 
PCT DOCDB 
Full family count within 
office 
1,917,261 1.09 2.46 0 41% 
PCT INPADOC Cited family count 1,917,261 13.22 87.36 2 63% 
PCT INPADOC 
Cited family count 
within office 
1,917,261 2.46 15.88 0 46% 
PCT INPADOC Full family count 1,917,261 8.63 50.28 1 63% 
PCT INPADOC 
Full family count within 
office 
1,917,261 2.31 14.11 0 46% 
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Table 4: Origin and destination of citations. Citations are calculated as originating from 
applications from any office in the PATSTAT database to applications at the EPO, USPTO and 
PCT. Family correction implies that the citation is made to the patent family of applications at 
the EPO,USPTO and PCT. The citations are expressed in percentages of all citations to the 
(patent family of) applications at the focal office. 
 
Family  
Correction 
Focal 
office 
EPO USPTO PCT EPO 
(National office)17 
Other Total Total citations 
received  
None EPO 31.35% 36.14% 19.84% 12.31% 0.36% 100% 4,501,136 
None USPTO 4.22% 85.28% 6.62% 3.74% 0.15% 100% 43,566,925 
None PCT 13.30% 31.33% 24.07% 30.72% 0.58% 100% 3,635,340 
DOCDB family EPO 12.03% 64.16% 14.58% 8.85% 0.39% 100% 21,160,972 
DOCDB family USPTO 6.45% 78.18% 8.54% 6.61% 0.22% 100% 57,379,697 
DOCDB family PCT 8.10% 52.14% 16.06% 23.40% 0.30% 100% 10,994,350 
INPADOC family EPO 10.33% 66.25% 15.17% 7.94% 0.31% 100% 39,950,651 
INPADOC family USPTO 6.99% 76.09% 10.69% 6.01% 0.22% 100% 114,120,819 
INPADOC family PCT 7.31% 56.65% 15.93% 19.86% 0.25% 100% 25,338,999 
 
 
 
Table 5: Statistics of INPADOC and DOCDB families in our applications 
Family Number of 
families 
% Singletons18 Average number of 
members 
Overlap between 
both family 
definitions 
% Overlap19 % Overlap20 
INPADOC 5,309,452 21% 2.64 4,179,052 79% 73% 
DOCDB 6,017,825 35% 2.01 4,179,052 69% 63% 
 
 
 
 
 
 
 
 
                                                 
17 Patent offices that are located in the geographical area covered by the EPO.  
18 Families with only one member. 
19 Including singletons. 
20 Excluding singletons. 
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Table 6: Correlation with the Application count within office indicator for each office.  
All correlations are significant at the 0.001 level. 
Family Compared indicator EPO USPTO PCT 
N/A Application count 0.79 0.99 0.77 
N/A Application count within office 1 1 1 
DOCDB Cited family count 0.34 0.84 0.35 
DOCDB Cited family count within office 0.64 0.86 0.72 
DOCDB Full family count 0.33 0.84 0.34 
DOCDB Full family count within office  0.65 0.86 0.72 
INPADOC Cited family count 0.09 0.23 0.14 
INPADOC Cited family count within office 0.20 0.25 0.19 
INPADOC Full family count 0.12 0.25 0.16 
INPADOC Full family count within office  0.26 0.28 0.22 
 
 
Table 7: Correlations between equal indicators derived from different sources. These 
correlations were calculated on the basis of 388,512 DOCDB families and are significant at the 
0.001 level. 
 Application count 
Application 
count 
within 
office 
DOCDB INPADOC 
Cited 
family 
count 
Cited 
family 
count 
within 
office 
Full 
family 
count  
Full 
family  
count 
within 
office 
Cited 
family 
count 
Cited 
family 
count 
within 
office 
Full 
family 
count 
Full 
family  
count 
within 
office 
EPO-USPTO 0.12 0.09 1 0.71 1 0.75 1 0.80 1 0.83 
EPO-PCT 0.11 0.04 1 0.91 1 0.91 1 0.91 1 0.91 
USPTO-PCT 0.30 0.20 1 0.78 1 0.81 1 0.93 1 0.95 
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Table 8: Result of clustering the patent citation indicators. 
Source Family Indicator Cluster R2 within cluster R2 closest 
Cluster 
ALL INPADOC Cited family count INPADOC 0.9636 0.3586 
ALL INPADOC Full family count INPADOC 0.9758 0.3918 
EPO INPADOC Cited family count within office INPADOC 0.789 0.7103 
EPO INPADOC Full family count within office INPADOC 0.7857 0.7261 
PCT INPADOC Cited family count within office INPADOC 0.9923 0.4306 
PCT INPADOC Full family count within office INPADOC 0.9948 0.4448 
USPTO INPADOC Cited family count within office INPADOC 0.9352 0.3164 
USPTO INPADOC Full family count within office INPADOC 0.9545 0.3606 
EPO DOCDB Cited family count within office DOCDB B 0.9795 0.4549 
EPO DOCDB Full family count within office DOCDB B 0.9816 0.4747 
PCT DOCDB Cited family count within office DOCDB B 0.9808 0.599 
PCT DOCDB Full family count within office DOCDB B 0.9805 0.602 
PCT N/A Application count PCT 0.9486 0.203 
PCT N/A Application count within office PCT 0.9486 0.2062 
USPTO N/A Application count USPTO 0.9998 0.2108 
USPTO N/A Application count within office USPTO 0.9998 0.2041 
EPO N/A Application count EPO 0.9536 0.2817 
EPO N/A Application count within office EPO 0.9536 0.2909 
ALL DOCDB Cited family count DOCDB A 0.9891 0.6409 
ALL DOCDB Full family count DOCDB A 0.9804 0.6734 
USPTO DOCDB Cited family count within office DOCDB A 0.9737 0.5847 
USPTO DOCDB Full family count within office DOCDB A 0.993 0.5187 
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Table 9: Qualified communalities between the ‘application count within office’ indicator 
and other indicators from the same office. Fractions are computed as the amount of overlap 
divided by the maximum amount of possible overlap. Top 100 refers to the 100 most cited 
patents and 5 sd. refers to patents present in the 5 standard deviation outlier of the distribution. 
Family Indicator 
EPO USPTO PCT 
Top 100 5 sd. Top 100 5 sd. Top 100 5 sd. 
N/A Application count 0.31 0.52 0.89 0.94 0.37 0.52 
N/A Application count within office 1 1 1 1 1 1 
DOCDB Cited family count 0.04 0.18 0.76 0.83 0.06 0.16 
DOCDB Cited family count within office 0.31 0.55 0.81 0.89 0.40 0.54 
DOCDB Full family count 0.05 0.18 0.75 0.82 0.06 0.15 
DOCDB Full family count within office 0.28 0.55 0.80 1.00 0.38 0.54 
INPADOC Cited family count 0.04 0.18 0.30 0.72 0.07 0.19 
INPADOC Cited family count within office 0.20 0.45 0.35 0.78 0.18 0.41 
INPADOC Full family count 0.04 0.18 0.28 0.66 0.06 0.17 
INPADOC Full family count within office 0.20 0.45 0.29 0.71 0.16 0.40 
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Table 10: Comparison between indicators at different offices. Commonality measures were 
computed by dividing the number of common members of highly cited groups by the maximum 
number of common members possible. 
Family Indicator USPTO – EPO USPTO – PCT EPO – PCT 
  Top 100 5 sd. outlier Top 100 5 sd. outlier Top 100 5 sd. outlier 
N/A Application count 0.02 0.09 0.03 0.07 0.00 0.02 
N/A 
Application 
count within 
office 
0.02 0.08 0.00 0.03 0.00 0.01 
DOCDB Cited family count 0.48 0.72 0.34 0.49 0.57 0.54 
DOCDB 
Cited family 
count within 
office 
0.08 0.21 0.16 0.19 0.14 0.19 
DOCDB Full family 0.45 0.70 0.30 0.46 0.56 0.53 
DOCDB Full family count within office 0.09 0.24 0.16 0.24 0.14 0.19 
INPADOC Cited family count 0.88 0.99 0.78 0.92 0.84 0.74 
INPADOC 
Cited family 
count within 
office 
0.40 0.37 0.43 0.41 0.45 0.33 
INPADOC Full family 0.85 0.99 0.76 0.87 0.85 0.73 
INPADOC Full family count within office 0.35 0.36 0.43 0.40 0.44 0.34 
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Table A1: Correlation of indicators of patents filed at the EPO. 
 
 Family Indicator 1 2 3 4 5 6 7 8 9 10 
1 N/A Application count 1.00                   
2 N/A Application count within office 0.79 1.00                 
3 DOCDB Cited family count 0.40 0.34 1.00               
4 DOCDB Cited family count within office 0.51 0.64 0.66 1.00             
5 DOCDB Full family count 0.39 0.33 0.99 0.65 1.00           
6 DOCDB Full family count within office  0.52 0.65 0.66 0.99 0.65 1.00         
7 INPADOC Cited family count 0.12 0.09 0.36 0.26 0.35 0.25 1.00       
8 INPADOC Cited family count within office 0.17 0.20 0.28 0.39 0.28 0.38 0.88 1.00     
9 INPADOC Full family count 0.14 0.12 0.40 0.30 0.40 0.30 0.91 0.77 1.00   
10 INPADOC Full family count within office  0.23 0.26 0.35 0.47 0.35 0.48 0.81 0.89 0.87 1.00 
 
 
Table A2: Correlation of indicators of patents filed at the USPTO. 
 Family Indicator 1 2 3 4 5 6 7 8 9 10 
1 N/A Application count 1.00          
2 N/A Application count within office 0.99 1.00         
3 DOCDB Cited family count 0.85 0.84 1.00        
4 DOCDB Cited family count within office 0.85 0.86 0.99 1.00       
5 DOCDB Full family 0.84 0.84 0.99 0.98 1.00      
6 DOCDB Full family count within office  0.85 0.86 0.98 0.99 0.99 1.00     
7 INPADOC Cited family count 0.23 0.23 0.30 0.31 0.30 0.30 1.00    
8 INPADOC Cited family count within office 0.25 0.25 0.31 0.32 0.31 0.32 0.99 1.00   
9 INPADOC Full family count 0.25 0.25 0.33 0.33 0.33 0.33 0.95 0.94 1.00  
10 INPADOC Full family count within office  0.27 0.28 0.34 0.35 0.35 0.35 0.94 0.95 0.99 1.00 
 
Table A3: Correlation of indicators of patents filed at the PCT. 
 Family Indicator 1 2 3 4 5 6 7 8 9 10 
1 N/A Application count 1.00          
2 N/A Application count within office 0.77 1.00         
3 DOCDB Cited family count 0.52 0.35 1.00        
4 DOCDB Cited family count within office 0.61 0.72 0.69 1.00       
5 DOCDB Full family count 0.49 0.34 0.99 0.68 1.00      
6 DOCDB Full family count within office  0.61 0.72 0.69 1.00 0.68 1.00     
7 INPADOC Cited family count 0.21 0.14 0.29 0.23 0.29 0.23 1.00    
8 INPADOC Cited family count within office 0.20 0.19 0.20 0.28 0.20 0.28 0.88 1.00   
9 INPADOC Full family count 0.22 0.16 0.32 0.26 0.32 0.26 0.93 0.82 1.00  
10 INPADOC Full family count within office 0.22 0.22 0.23 0.31 0.23 0.31 0.84 0.94 0.88 1.00 
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Table B1: Correlation coefficients of indicators pertaining to patents filed both at the EPO 
(columns) and the USPTO (rows)  
 
Office Indicator 
number 
Family Office EPO EPO EPO EPO EPO EPO 
Indicator 1 2 3 4 5 6 
USPTO 1 N/A Application count 0.12 0.09 0.27 0.28 0.17 0.18 
USPTO 2 N/A Application count within office 0.12 0.09 0.27 0.27 0.17 0.18 
USPTO 3 DOCDB Cited family count within office 0.11 0.06 0.71 0.72 0.81 0.82 
USPTO 4 DOCDB Full family count within office 0.12 0.07 0.74 0.75 0.82 0.83 
USPTO 5 INPADOC Cited family count within office 0.01 0.00 0.39 0.40 0.80 0.80 
USPTO 6 INPADOC Full family count within office 0.02 0.00 0.43 0.45 0.82 0.83 
 
 
Table B2: Correlation coefficients of indicators pertaining to patents filed both at the EPO 
(columns) and the PCT (rows).  
Office Indicator 
number 
Family Office EPO EPO EPO EPO EPO EPO 
Indicator 1 2 3 4 5 6 
PCT 1 N/A Application count 0.11 0.07 0.47 0.47 0.33 0.33 
PCT 2 N/A Application count within office 0.07 0.04 0.34 0.33 0.22 0.22 
PCT 3 DOCDB Cited family count within office 0.16 0.10 0.91 0.91 0.82 0.82 
PCT 4 DOCDB Full family count within office 0.16 0.10 0.91 0.91 0.82 0.82 
PCT 5 INPADOC Cited family count within office 0.03 0.01 0.54 0.55 0.91 0.91 
PCT 6 INPADOC Full family count within office 0.04 0.01 0.55 0.56 0.92 0.91 
 
Table B3: Correlation coefficients of indicators pertaining to patents filed both at the 
USPTO (columns) and the PCT (rows).  
Office Indicator 
number 
Family Office  US 
PTO 
US 
PTO 
US 
PTO 
US 
PTO 
US 
PTO 
US 
PTO 
Indicator 1 2 3 4 5 6 
PCT 1 N/A Application count 0.30 0.29 0.37 0.38 0.11 0.13 
PCT 2 N/A Application count within office 0.20 0.19 0.22 0.23 0.04 0.06 
PCT 3 DOCDB Cited family count within office 0.31 0.30 0.78 0.81 0.48 0.52 
PCT 4 DOCDB Full family count within office 0.31 0.30 0.78 0.81 0.48 0.52 
PCT 5 INPADOC Cited family count within office 0.10 0.10 0.78 0.76 0.93 0.94 
PCT 6 INPADOC Full family count within office 0.10 0.11 0.79 0.78 0.94 0.95 
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